Ardent Health Partners’ (ARDT) “Neutral” Rating Reaffirmed at JPMorgan Chase & Co.

Ardent Health Partners (NYSE:ARDT)‘s stock had its “neutral” rating reiterated by stock analysts at JPMorgan Chase & Co. in a research note issued on Tuesday,Benzinga reports. They presently have a $20.00 price target on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 20.26% from the stock’s previous close.

A number of other analysts have also recently weighed in on the stock. Leerink Partners upped their price target on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 12th. Stephens reiterated an “overweight” rating and issued a $24.00 target price on shares of Ardent Health Partners in a research note on Thursday, September 19th. Bank of America lowered Ardent Health Partners from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $22.00 to $19.00 in a research report on Wednesday, November 6th. KeyCorp assumed coverage on shares of Ardent Health Partners in a research report on Friday, October 11th. They issued an “overweight” rating and a $24.00 price objective for the company. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $23.00 target price on shares of Ardent Health Partners in a research report on Thursday, November 14th. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, Ardent Health Partners presently has a consensus rating of “Buy” and a consensus price target of $22.00.

Ardent Health Partners Stock Down 0.4 %

NYSE ARDT opened at $16.63 on Tuesday. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. Ardent Health Partners has a 1-year low of $14.57 and a 1-year high of $20.72. The company has a 50-day moving average price of $17.41.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the company. BNP Paribas Financial Markets acquired a new position in Ardent Health Partners in the third quarter worth $42,000. Financial Management Professionals Inc. bought a new stake in shares of Ardent Health Partners during the 3rd quarter valued at about $50,000. MetLife Investment Management LLC acquired a new stake in Ardent Health Partners during the third quarter worth about $135,000. Quadrature Capital Ltd bought a new position in Ardent Health Partners in the third quarter worth about $229,000. Finally, Barclays PLC bought a new position in shares of Ardent Health Partners during the third quarter valued at approximately $385,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.